Drug Database · Clinicians

Piracetam

Brands (23) Neurocetam, Nurocer, Boricetam…Show all

Nootropic (other psychostimulant and nootropic); Psychoanaleptic (other psychostimulant and nootropic); and others PH FDA category

Dose by CrCl; contraindicated in ESKDRx · Prescription drug30 PH productsVAT-exempt Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Contraindications

  • End-stage kidney disease
  • Cerebral hemorrhage
  • Huntington chorea
  • Hypersensitivity to piracetam or other pyrrolidone derivatives
renalcarematters.com, reviewed

Dosing: Adult

  • Cortical myoclonus: Start 7.2 g/day, increase by 4.8 g/day every 3 to 4 days to a maximum of 24 g/day in 2 or 3 doses; taper by 1.2 g every 2 days when stopping
  • Psycho-organic syndromes or vertigo: 2.4 to 4.8 g/day in 2 or 3 doses
renalcarematters.com, reviewed

Dosing: Altered kidney function

About 90% of piracetam is excreted unchanged in urine, so the dose falls in steps with creatinine clearance (CrCl): two-thirds at 50–79, one-third at 30–49 and one-sixth (once daily) below 30 mL/min. It is contraindicated in end-stage kidney disease, and hemodialysis removes 50% to 60%. It also inhibits platelet aggregation. It has no US FDA label.

Kidney function measure: European core safety profile uses creatinine clearance (CrCl, mL/min; Cockcroft–Gault, ×0.85 for women).

Show full dosing details
CrCl ≥60 mL/min
CrCl >80: usual dose in 2 to 4 divided doses (e.g., 2.4 to 4.8 g/day; up to 24 g/day for cortical myoclonus). CrCl 60–79: two-thirds of the usual dose in 2 or 3 divided doses (CSP).
CrCl 30–59 mL/min
CrCl 50–59: two-thirds of the usual daily dose in 2 or 3 divided doses. CrCl 30–49: one-third of the usual daily dose in 2 divided doses (CSP).
CrCl 15–29 mL/min
CrCl <30: one-sixth of the usual daily dose as a single daily dose (CSP).
CrCl <15 mL/min (not on dialysis)
CrCl <30: one-sixth of the usual daily dose once daily. End-stage kidney disease: contraindicated (CSP). Equating CrCl <15 with end-stage disease is our judgment; we keep it red because piracetam is renally cleared, of marginal benefit and affects platelets in a population prone to uremic bleeding.
Hemodialysis (intermittent)
Contraindicated in end-stage kidney disease (CSP). Hemodialysis removes 50% to 60% (dialyzer extraction), useful in overdose.
Peritoneal dialysis
Contraindicated in end-stage kidney disease (CSP).
CRRT
Not appropriate; contraindicated in end-stage kidney disease and no data in acute kidney injury.
  • Dialyzable? Yes: hemodialysis extraction efficiency 50% to 60% (CSP 4.9).
  • Monitoring Creatinine clearance regularly in older adults and long-term use. Bleeding risk (platelet inhibition): caution with anticoagulants, antiplatelets, ulcer, recent surgery or hemorrhagic stroke. Do not stop abruptly in myoclonus (CSP 4.4).
Children (kidney dosing)
Show full dosing details
eGFR ≥60
Normal kidney function: usual pediatric doses (CSP).
eGFR 30–59
No pediatric-specific table; the adult CrCl-based fractions are the only guide (renally cleared drug). Specialist input.
eGFR 15–29
No pediatric-specific table; the adult CrCl-based fractions are the only guide (renally cleared drug). Specialist input.
eGFR <15 (not on dialysis)
No pediatric-specific table; the adult CrCl-based fractions are the only guide (renally cleared drug). Specialist input.
Hemodialysis (intermittent)
Contraindicated in end-stage kidney disease.
Peritoneal dialysis
Contraindicated in end-stage kidney disease.
CRRT
Contraindicated in end-stage kidney disease.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

Source: CBG-MEB (Netherlands) product information. This generic has no US FDA label.

Dosing: Pediatric

Approved ages
Dyslexia from 8 years; sickle cell crises from 3 years (limited data 1 to 3 years) (CSP).
Usual dose
Dyslexia (8 years and older): about 3.2 g/day in 2 doses. Sickle cell: 160 mg/kg/day orally (prophylaxis); 300 mg/kg/day intravenously (crisis) (CSP).

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed

Dosage forms

Philippines

  • Film-coated tablet: 1.2 g, 800 mg
  • Capsule: 400 mg
  • Solution for injection: 200 mg/mL
  • ) solution for injection: 200 mg/mL (1 g/5 mL
  • Tablet: 1.2 g, 800 mg
  • ) solution for infusion: 200 mg/mL (1 g/5 mL

Registered products in the Philippines

30 products registered with the Food and Drug Administration (FDA) Philippines list Piracetam as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products30
Philippine FDA-registered products for Piracetam
Package insert
BoricetamPiracetam
200 mg/mL (1 g/5 mL) Solution for Injection (I.M./I.V.)Type I Amber Glass Ampoule in 5 mL (net content) (Box of 10’s)
RxVAT-exempt
Brawn Laboratories LimitedIndia
L’Keeran EnterprisesImporter: Ambica International Corporation
DRP-8045
Dec 5, 2028
BoricetamPiracetam
400 mg CapsuleAlu/PVC Blister Pack x 10’s (Box of 100 capsules)
RxVAT-exempt
Brawn Laboratories Ltd.India
Ambica International Corporation
DRP-6662
Apr 27, 2037
CognizetPiracetam
200mg/ml Solution for Injection (IV/IM/SC)Clear glass ampoule with band x 5mL (Box of 1's)
RxVAT-exempt
Sanjar Pharma LLPIndia
Aglobal Care, Inc.
DRP-15550
Aug 5, 2029
EmbolPiracetam
200 mg/mL Solution for Injection (I.M./I.V.)Ampoule x 5 mL (Box of 10's)
RxVAT-exempt
Yung Shin Pharm. Ind. Co., Ltd. - Taichung Youth FactoryTaiwan
Philgen Pharmaceuticals Inc.Importer: Yung Shin (Philippines), Inc.
DR-XY12988
Dec 6, 2030
EmbolPiracetam
200 mg/mL Solution For Injection (IM/IV)USP Type I clear glass ampoule x 5 mL (Box of 10's)
RxVAT-exempt
Y.S.P. Industries (M) SDN. BHD.Malaysia
Yung Shin (Philippines), Inc.
DR-XY48306
Aug 22, 2027
EucetPiracetam
1.2 g Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Medirich Pharma Distribution Corp.Trader: Euro-Health Care Exponents, Inc.
DRP-2913
May 15, 2031
IracetPiracetam
400 mg CapsuleBlister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Tgp Pharma Inc.Trader: Foramen Products Corporation
DR-XY31588
Apr 7, 2031
IracetPiracetam
800 mg Film-Coated TabletBlister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Foramen Products Corporation
DR-XY31790
May 25, 2031
KnowfulPiracetam
800 mg Film-Coated TabletAlu/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Y.S.P. Industries (M) Sdn. BhdMalaysia
Yung Shin (Philippines), Inc.
DR-XY49133
Aug 14, 2029
NeuracetPiracetam
200 mg/mL Solution for Injection (IM/IV)Type I Clear Colorless Ampoule x 20 mL (Box of 5's)
RxVAT-exempt
Shanghai Xudong Haipu Pharmaceutical Co., Ltd.China
Endure Medical, Inc.
DR-XY43515
Jul 10, 2029
NeurocetamPiracetam
1.2 g TabletAlu/PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Phils., Inc.
DR-XY42110
Jun 13, 2028
NeurocetamPiracetam
200 mg/mL Solution for Injection ( iM/IV)USP Type I Clear Glass Ampoule x 15 mL (Box of 4's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Phils., Inc.
DR-XY35480
Nov 7, 2031
NeurocetamPiracetam
800 mg tabletAlu/ Orange PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.Importer: Brown & burk Philippines Inc.
DR-XY34886
Sep 3, 2031
NeurotamPiracetam
800 mg Film-Coated TabletAlu-PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Totalcare Pharma Inc.
DRP-16441
Sep 20, 2030
NeutrotopPiracetam
1.2 g Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Randril International Co., Inc.
DRP-4345
Apr 12, 2027
NootropilPiracetam
800 mg Film-Coated Tablet
RxVAT-exempt
UCB Pharma S.A.
Importer: GlaxoSmithKline Philippines Inc.
DR-X5323
Dec 28, 2026
NootrotamPiracetam
200 mg/mL (1 g/5 mL) Solution for Infusion (I.M./I.V.)5 mL Type I amber glass ampoule (Box of 12's)
RxVAT-exempt
Osel Ilaç San. Ve Tic A.Ş.Turkey
Access Point International Trading Inc.Importer: Accesspoint International Trading, Inc.
DRP-11799
Apr 29, 2027
Normabrain-800Piracetam
800 mg Film-Coated TabletAlu Foil Strip x 10's (Box of 50's)
RxVAT-exempt
Torrent Pharmaceuticals Ltd.India
Torrent Pharma Philippines Inc.
DRP-2764
Nov 17, 2031
NurocerPiracetam
1.2 g Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-9910
Nov 22, 2029
NurocerPiracetam
400 mg CapsuleBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-9990
Apr 21, 2030
NurocerPiracetam
800 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-9911
Nov 19, 2029
Nurocer IVPiracetam
200 mg/mL (1 g/5 mL) Solution for Injection (I.M./I.V.)Type I Amber Glass Ampoule in 5 mL (net content) (Box of 10’s)
RxVAT-exempt
Brawn Laboratories LimitedIndia
Innogen Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-8045-01
Dec 5, 2028
PerixlPiracetam
800 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3990-01
Mar 22, 2032
ProtamPiracetam
1.2 g Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Aldril Phamraceuticals, Inc.Trader: Randril Internation Co., Inc.
DRP-4345-01
Apr 12, 2027
Retento-400Piracetam
400 mg CapsuleAlu-Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-3061
Jun 16, 2032
Retento-800Piracetam
800 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box 30’s and 60’s)
RxVAT-exempt
Xl Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-3990
Mar 22, 2032
Saphcetam-400Piracetam
400 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Ollen Pharma Trading, Inc.
DRP-12882
Oct 24, 2027
Saphcetam-800Piracetam
800mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Ollen Pharma Trading, Inc.
DRP-12803
Oct 7, 2027
Saphneuropi-GE800Piracetam
800 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-18949
Oct 6, 2031
ZystamPiracetam
800 mg Film-Coated TabletAlu/PVDC Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
The Schazoo Pharmaceutical Laboratories (Pvt) Ltd.Pakistan
Zuneca Inc.
DR-XY36957
Nov 11, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Drug interactions

Drug or classSeverityEffectWhat to do
Anticoagulants, antiplatelets (including low-dose aspirin)Adjust or monitorPiracetam lowers platelet aggregation, fibrinogen and von Willebrand factor.Use with caution; watch for bleeding.
Thyroid hormones (T3 plus T4)MinorConfusion, irritability, sleep disorder reported.Monitor.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed

Adverse reactions

Common

  • Nervousness
  • Hyperkinesia
  • Weight gain

Serious

  • Bleeding (hemorrhagic disorder)
  • Anaphylactoid reactions, angioedema
  • Aggravated epilepsy, hallucinations
renalcarematters.com, reviewed

Monitoring parameters

  • Creatinine clearance regularly in older adults and long-term use. Bleeding risk (platelet inhibition): caution with anticoagulants, antiplatelets, ulcer, recent surgery or hemorrhagic stroke. Do not stop abruptly in myoclonus (CSP 4.4). Kidney
  • Creatinine clearance in older adults and long-term use
  • Bleeding signs
renalcarematters.com, reviewed

Pharmacokinetics

Key PK parameters

Renal excretion kidneyAbout 90% unchanged in urine
Dialyzability kidneyYes (hemodialysis extraction 50% to 60%)
renalcarematters.com, reviewed

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Medicines Evaluation Board (CBG-MEB), Netherlands. Piracetam proposed core safety profile (sections 4.2–4.9) [CBG-MEB (Netherlands) product information; no US FDA label]. https://db.cbg-meb.nl/veegactie/csp/piracetam-6-2010.pdf
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. College ter Beoordeling van Geneesmiddelen (Medicines Evaluation Board, Netherlands). (n.d.; c. 2010). Piracetam: Proposed core safety profile, sections 4.2–4.9 [Harmonization document]. Retrieved November 17, 2026. https://db.cbg-meb.nl/veegactie/csp/piracetam-6-2010.pdf

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .